Tamarack Advisers as of Dec. 31, 2019
Portfolio Holdings for Tamarack Advisers
Tamarack Advisers holds 29 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medtronic | 10.0 | $44M | 385k | 113.88 | |
| Bio-Rad Laboratories (BIO) | 8.4 | $37M | 100k | 366.70 | |
| Allscripts Healthcare Solutions (MDRX) | 8.0 | $35M | 3.7M | 9.63 | |
| AtriCure (ATRC) | 6.4 | $28M | 860k | 32.46 | |
| Pacira Pharmaceuticals (PCRX) | 6.3 | $28M | 623k | 44.68 | |
| Quest Diagnostics Incorporated (DGX) | 5.9 | $26M | 245k | 105.08 | |
| Hologic (HOLX) | 5.6 | $25M | 475k | 51.89 | |
| Iveric Bio | 4.9 | $22M | 2.7M | 8.14 | |
| Stericycle (SRCL) | 4.2 | $19M | 300k | 61.97 | |
| Zimmer Holdings (ZBH) | 4.2 | $19M | 125k | 148.75 | |
| Johnson & Johnson (JNJ) | 4.1 | $18M | 125k | 144.28 | |
| Phreesia (PHR) | 4.0 | $18M | 660k | 26.59 | |
| Portola Pharmaceuticals | 3.3 | $14M | 595k | 23.98 | |
| Integer Hldgs (ITGR) | 3.0 | $13M | 165k | 81.01 | |
| United Therapeutics Corporation (UTHR) | 3.0 | $13M | 151k | 86.46 | |
| ICU Medical, Incorporated (ICUI) | 3.0 | $13M | 70k | 185.50 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 2.9 | $13M | 650k | 19.19 | |
| Rigel Pharmaceuticals | 2.7 | $12M | 5.8M | 2.05 | |
| Mylan | 2.1 | $9.1M | 450k | 20.20 | |
| Optinose (OPTN) | 2.0 | $8.6M | 1.1M | 8.16 | |
| RadNet (RDNT) | 1.9 | $8.3M | 400k | 20.67 | |
| Streamline Health Solutions (STRM) | 1.4 | $6.0M | 4.3M | 1.39 | |
| Inogen (INGN) | 1.1 | $5.0M | 75k | 66.35 | |
| Nevro (NVRO) | 1.1 | $4.7M | 40k | 118.00 | |
| Correvio Pharma Corp | 0.2 | $1.0M | 2.5M | 0.41 | |
| Spdr S&p 500 Etf Tr option | 0.1 | $512k | 8.0k | 64.00 | |
| Charles River Laboratories cmn | 0.1 | $279k | 218.00 | 1279.82 | |
| Johnson & Johnson call | 0.0 | $125k | 250.00 | 500.00 | |
| Haemonetics Corporation Cmn Stk cmn | 0.0 | $24k | 500.00 | 48.00 |
